Ñ¡ÔñËØ,SelectinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ѫ¹ÜÉú³ÉËØ,AngiopoietinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
΢˿,microfilamentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ʧ³²µòÍö,anoikisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂÑÁ×Ö¬,lecithinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÍÑ¿ÅÁ£,degranulationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
È¥ÕûºÏËØ,disintegrinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°ûÉúÎïѧ,cell biologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÖØ±à³Ì,reprogrammingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»·ÏÙÜÕËá,cAMPÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼¤Ã¸,kinaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°ûÍÂ,exocytosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼îÐÔ³ÉÏËάÉú³¤Òò×Ó,basic fibroblast growth factorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
΢ÐÍ»úµçϵͳ,MEMSÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°û»µËÀ,NecrosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°ûÖÊ·ÖÁÑ,CytokinesisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±í¹ÛÒÅ´«,epigeneticsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼¡³ÉÏËάϸ°û,MyofibroblastÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ¥Í¨µÀ,single channelÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°ûÍâÐźŵ÷½Ú¼¤Ã¸1/2,ERK1/2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
СÎѵ°°×-1,caveolin-1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°û×ÔÊÉ,autophagyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐÄÁ×Ö¬,cardiolipinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸º·´À¡,negative feedbackÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÃÅ¿Ø,GatingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³É¼¡ÏËάϸ°û,myofibroblastÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ȱÑõ/¸´Ñõ,Hypoxia/ReoxygenationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ñîÁª,couplingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éñ¾õ£°·,ceramideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µçÉøÍ¸,electroosmosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ÷½Ú¼Á,regulatorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÎÞ¼¹×µ¶¯Îï,invertebrateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈÜѪÂÑÁ×Ö¬,lysophosphatidylcholineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼×¿ÇËØ/¿Ç¾ÛÌÇ,chitin/chitosanÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹Çϸ°û,osteocytesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ºË¶¨Î»ÐźÅ,nuclear localization signalÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö¬¶àÌÇ(LPS),lipopolysaccharide(LPS)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊÈÖÐÐÔÁ£Ï¸°û,neutrophilÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
СÎѵ°°×,CaveolinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Caspase-3,Bcl-2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°ûÍÂ×÷ÓÃ,ExocytosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ô¶ºìÍâÏß,far-infraredÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉúÎï΢»úµçϵͳ,BioMEMSÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Gµ°°×żÁªÊÜÌå,G protein-coupled receptorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ä©¶Ë×ªÒÆÃ¸,TelomeraseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×ÔÊÉÌå,autophagosomeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éú³¤³Ù»º,stuntingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ô×ÓÁ¦ÏÔ΢Êõ,Atomic force microscopyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿¹µòÍö,anti-apoptosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°ûÕ³¸½,Cell adhesionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
SUMO»¯,SUMOylationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Á×Ëữ,phosphorylationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶àÄÜÐÔ,PluripotencyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö¬Àà×éѧ,lipidomicsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
΢¹Ü¹Ç¼Ü,MicrotubulesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÚÆ¤ËØ-1(ET-1),endothelin-1(ET-1)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼×»ùÏõ»ùÑÇÏõ»ùëÒ,MNNGÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Smad,SmadsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈéÏÙ°©Ò׸лùÒò2,BRCA2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈýͨµÀ,three-channelÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÓÐÏÞʱÓò²î·Ö,FDTDÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉúÎïĤÅÝ,vesicleÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°û·ÖÀà,cytotaxonomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Á×õ£»¯,phosphorylationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
רéµõ£»¯,palmitoylationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ѫºìϸ°û,red blood cellÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÃâÒßÓ«¹âϸ°û»¯Ñ§,ImmunofluorescenceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
CCK,CholecystokininÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µçÉúÀíÌØÐÔ,Electrophysiological characteristicsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ð¤Á¬,AdhesionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
È¥¼×»ù»¯Ã¸,demethylaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°ëë×Ì춬µ°°×ø-3,caspase-3Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐØÏÙëÄ-¦Â4,thymosin-¦Â4Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°ûĤСÎÑ,caveolaeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µç×ÓÏÔ΢ѧ,electron microscopyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Àä¶³ËðÉË,Cryo-damageÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
α×ã,pseudopodiumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Á¦Ñ§×ªµ¼,MechanotransductionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Hdac1,Hdac3Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ËÕËØ»¯,sumoylationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÇÊÖ¬Àà,sphingolipidÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×ÔÉíÏ໥×÷ÓÃ,self-interactionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÎÊÌâÉèÖÃ,QuestioningÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼×õ£¼×Áò°±õ£-ÁÁ°±õ£-±½±û°±Ëá,fMLPÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°û³ÉÁöÐÔ,oncogenesisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸¨Öúµ÷½ÚÒò×Ó,CoregulatorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
RNAi¸ÉÈÅ,RNAiÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·ÇÂÉÆ½¾úËØ,FilipinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×ÔÊÉ»ùÒò,autophagygeneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ó«¹â³ÉÏñ¼¼Êõ,Imaging-PAMÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
PLC-¦Ã,PLC-¦Ã_1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
΢µç¼«×é,multimicroelectrodeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊÜÌåÏ໥×÷Óõ°°×3,RIP3Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÍÑÇâø¸¨Ã¸,NAD(P)HÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÉÃ×ÉúÎïÁ¦Ñ§,Nano-biomechanicsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
2-°±»ùÒÒÑõ»ù¶þ±½»ùÅðËáÑÎ,2-APBÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿â×÷ÐÔ¸ÆÄÚÁ÷,SOCEÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Vav1·Ö×Ó,Vav1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌÇÇÊÖ¬Gb3,globotriaosylceramideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µÚ10¸öÈÜÖÊתÔ˵°°×¼Ò×å,SLC10Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«

|